Compugen Ltd. (TLV:CGEN)
Israel
· Delayed Price · Currency is ILS · Price in ILA 473.90
+9.80 (2.11%)
May 13, 2025, 5:24 PM IDT
Compugen Market Cap
Compugen has a market cap or net worth of 449.13 million as of May 13, 2025. Its market cap has decreased by -31.49% in one year.
Market Cap
449.13M
Enterprise Value
92.14M
Revenue
101.49M
Ranking
n/a
PE Ratio
n/a
Stock Price
473.90
Market Cap Chart
Since August 11, 2000, Compugen's market cap has increased from 289.89M to 449.13M, an increase of 54.93%. That is a compound annual growth rate of 1.78%.
Market Cap History
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Teva Pharmaceutical Industries | 73.61B |
| Danel (Adir Yeoshua) | 2.35B |
| Kamada | 1.39B |
| Bait Bakfar | 1.15B |
| Novolog (Pharm-Up 1966) | 779.55M |
| SofWave Medical | 722.24M |
| Ilex Medical | 680.80M |
| BrainsWay | 586.43M |